Psychosocial Impact of Predictive Genetic Testing in Hereditary Heart Diseases: The PREDICT Study

Predictive genetic testing (PGT) is offered to asymptomatic relatives at risk of hereditary heart disease, but the impact of result disclosure has been little studied. We evaluated the psychosocial impacts of PGT in hereditary heart disease, using self-report questionnaires (including the State-Trait Anxiety Inventory) in 517 adults, administered three times to the prospective cohort (PCo: n = 264) and once to the retrospective cohort (RCo: n = 253). The main motivations for undergoing PGT were “to remove doubt” and “for their children”. The level of anxiety increased between pre-test and result appointments (p <0.0001), returned to baseline after the result (PCo), and was moderately elevated at 4.4 years (RCo). Subjects with a history of depression or with high baseline anxiety were more likely to develop anxiety after PGT result (p = 0.004 and p <0.0001, respectively), whatever it was. Unfavourable changes in professional and/or family life were observed in 12.4% (PCo) and 18.7% (RCo) of subjects. Few regrets about PGT were expressed (0.8% RCo, 2.3% PCo). Medical benefit was not the main motivation, which emphasises the role of pre/post-test counselling. When PGT was performed by expert teams, the negative impact was modest, but careful management is required in specific categories of subjects, whatever the genetic test result.

[1]  J. Ingles.  Psychological Issues in Managing Families with Inherited Cardiovascular Diseases. , 2019, Cold Spring Harbor perspectives in medicine.

[2]  G. Pravettoni,et al.  A Systematic Review of the Psychological Implications of Genetic Testing: A Comparative Analysis Among Cardiovascular, Neurodegenerative and Cancer Diseases , 2018, Front. Genet..

[3]  A. Marian.  Genetic Testing in Cardiovascular Medicine. , 2018, Texas Heart Institute journal.

[4]  W. Chung,et al.  Examining the Psychosocial Impact of Genetic Testing for Cardiomyopathies , 2018, Journal of Genetic Counseling.

[5]  C. Caleshu,et al.  Role of Genetic Testing in Inherited Cardiovascular Disease: A Review , 2017, JAMA cardiology.

[6]  E. Ashley,et al.  Interdisciplinary psychosocial care for families with inherited cardiovascular diseases. , 2016, Trends in cardiovascular medicine.

[7]  D. Craufurd,et al.  22 Years of predictive testing for Huntington’s disease: the experience of the UK Huntington’s Prediction Consortium , 2016, European Journal of Human Genetics.

[8]  D. Craufurd,et al.  22 Years of predictive testing for Huntington’s disease: the experience of the UK Huntington’s Prediction Consortium , 2016, European Journal of Human Genetics.

[9]  F. Rutten,et al.  [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy]. , 2014, Kardiologia polska.

[10]  Siobhan M. Dolan,et al.  Motivation to Pursue Genetic Testing in Individuals with a Personal or Family History of Cardiac Events or Sudden Cardiac Death , 2014, Journal of Genetic Counseling.

[11]  W. Chung,et al.  The effect of cardiac genetic testing on psychological well-being and illness perceptions. , 2014, Heart & lung : the journal of critical care.

[12]  Jennifer M. Taber,et al.  Melanoma Genetic Counseling and Test Reporting Improve Screening Adherence Among Unaffected Carriers 2 Years Later , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[13]  R. Macleod,et al.  Experiences of predictive testing in young people at risk of Huntington’s disease, familial cardiomyopathy or hereditary breast and ovarian cancer , 2013, European Journal of Human Genetics.

[14]  H. Watkins,et al.  Pre-symptomatic genetic testing for inherited cardiac conditions: a qualitative exploration of psychosocial and ethical implications , 2013, European Journal of Human Genetics.

[15]  A. Sturm,et al.  Genetic testing in cardiovascular medicine: current landscape and future horizons , 2013, Current opinion in cardiology.

[16]  H. Skirton,et al.  Quality in genetic counselling for presymptomatic testing — clinical guidelines for practice across the range of genetic conditions , 2012, European Journal of Human Genetics.

[17]  P. Scuffham,et al.  Genetic testing for inherited heart diseases: longitudinal impact on health-related quality of life , 2012, Genetics in Medicine.

[18]  E. Leray,et al.  Prevalence, characteristics and comorbidities of anxiety disorders in France: Results from the “Mental Health in General Population” Survey (MHGP) , 2011, European Psychiatry.

[19]  Michael J Ackerman,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[20]  A. Keren,et al.  Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2010, European heart journal.

[21]  G. Bonsel,et al.  Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: The patients' perspective , 2009, American journal of medical genetics. Part A.

[22]  J. Lubiński,et al.  Identification of patients at high risk of psychological distress after BRCA1 genetic testing. , 2009, Genetic testing and molecular biomarkers.

[23]  A. Durr,et al.  Long-term outcome of presymptomatic testing in Huntington disease , 2009, European Journal of Human Genetics.

[24]  M. Hendriks,et al.  Familial disease with a risk of sudden death: a longitudinal study of the psychological consequences of predictive testing for long QT syndrome. , 2008, Heart rhythm.

[25]  R. Roos,et al.  Adverse effects of predictive testing for Huntington disease underestimated: long-term effects 7-10 years after the test. , 2004, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[26]  S. Wiggins,et al.  Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease , 2003, Clinical genetics.

[27]  A. Durr,et al.  Presymptomatic testing in Huntington’s disease and autosomal dominant cerebellar ataxias , 2002, Neurology.

[28]  M. Komajda,et al.  Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experience , 2002, Journal of medical genetics.

[29]  S. Michie,et al.  Psychological consequences of predictive genetic testing: a systematic review , 2000, European Journal of Human Genetics.

[30]  International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease. , 1994, Journal of medical genetics.

[31]  Sandi Wiggins,et al.  The Psychological Consequences of Predictive Testing for Huntington’s Disease , 1992 .

[32]  M. Horowitz,et al.  Impact of Event Scale: A Measure of Subjective Stress , 1979, Psychosomatic medicine.

[33]  C. Spielberger,et al.  Digit span: An indicant of trait or state anxiety? , 1969 .

[34]  G. Evers‐Kiebooms,et al.  A theoretical psychological perspective on predictive testing for late onset hereditary diseases. , 2007, Genetic counseling.

[35]  K. Demyttenaere,et al.  Psychological distress in the 5-year period after predictive testing for Huntington's disease , 2003, European Journal of Human Genetics.